Blindness

At that time, little was known about these blinding retinal degenerative diseases. Very little research was being done, and there were no clinical trials for potential treatments. The Foundation's goal was clear and focused: To drive the research that would lead to preventions, treatments, and vision restoration for the spectrum of degenerative ret... inal diseases, specifically macular degeneration - including age related macular degeneration, retinitis pigmentosa, Usher syndrome, Stargardt disease and Leber congenital amurosis (LCA). Together these conditions affect more than 10 million Americans and millions more throughout the world. Today, the Foundation Fighting Blindness is the world's leading private funder of retinal disease research. That funding has been a driving force behind the progress toward cures, including the identification of more than 250 genes linked to retinal disease, and the launch of 20 clinical trials for potential treatments. On an annual basis, the Foundation Fighting Blindness and the Foundation's Clinical Research Institute fund more than 100 research grants. The research projects are conducted by more than 150 research investigators at institutions, eye hospitals, and universities in the United States, Australia, England, France, Germany, The Netherlands, Italy, Israel, and Mexico. More about the Foundation Fighting BlindnessRead More